Pelthos Therapeutics (PTHS) EPS (Basic) (QoQ) (2023 - 2026)
Powered by 
Analysis
Pelthos Therapeutics (PTHS) EPS (Basic) (QoQ) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.22 Bn | 620.47 Bn | 17.26 Bn |
| 2 | AbbVie | 446.22 Bn | 439.65 Bn | 12.70 Bn |
| 3 | Merck | 357.04 Bn | 349.90 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.38 Bn | 260.69 Bn | 11.24 Bn |
| 5 | Pfizer | 156.32 Bn | 144.62 Bn | 10.94 Bn |
| 6 | Sanofi | 52.23 Bn | 44.85 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.18 Bn | 43.18 Bn | - |
| 8 | Incyte | 24.85 Bn | 20.31 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.29 Bn | 18.62 Bn | 683.80 Mn |
| 10 | Pelthos Therapeutics | 80.38 Mn | 55.82 Mn | 21.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -80.95% |
| Mar 31, 2026 | 34.28% |
| Dec 31, 2025 | -117.20% |
| Sep 30, 2025 | -197.07% |
| Jun 30, 2025 | 270.15% |
| Mar 31, 2025 | 7.05% |
| Dec 31, 2024 | -18.07% |
| Sep 30, 2024 | 4.63% |
| Jun 30, 2024 | 43.82% |
| Mar 31, 2024 | 82.74% |
| Dec 31, 2023 | -119.11% |
| Sep 30, 2023 | -51.90% |
| Jun 30, 2023 | -9.29% |